Mama's Creations (MAMA) 10-Q 16 Dec 24 2025 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2024	Dec. 16, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2024
Document Transition Report	false
Entity File Number	001-40597
Entity Registrant Name	Mama’s Creations, Inc.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	27-0607116
Entity Address, Address Line One	25 Branca Road
Entity Address, City or Town	East Rutherford
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07073
City Area Code	201
Local Phone Number	531-1212
Title of 12(b) Security	Common Stock, par value $0.00001
Trading Symbol	MAMA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		37,586,897
Entity Central Index Key	0001520358
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q3
Amendment Flag	false
Current Fiscal Year End Date	--01-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Current Assets:
Cash and cash equivalents	$ 9,319	$ 11,022
Accounts receivable, net	8,567	7,859
Inventories, net	3,190	3,310
Prepaid expenses and other current assets	929	1,375
Total Current Assets	22,005	23,566
Property, plant, and equipment, net	9,849	4,436
Intangible assets, net	3,822	4,979
Goodwill	8,633	8,633
Operating lease right of use assets, net	3,080	2,889
Deferred tax asset	413	503
Deposits	95	95
Total Assets	47,897	45,101
Current Liabilities:
Accounts payable and accrued expenses	13,845	12,425
Term loan, net of unamortized debt discount of $25 and $38, respectively	1,527	1,514
Operating lease liabilities	844	434
Finance leases payable	369	367
Promissory notes – related parties	2,250	1,950
Total Current Liabilities	18,835	16,690
Line of credit	0	0
Term loan – net of current	1,730	3,003
Operating lease liabilities – net of current	2,309	2,515
Finance leases payable – net of current	1,275	1,062
Promissory note – related party, net of current	750	2,250
Total long-term liabilities	6,064	8,830
Total Liabilities	24,899	25,520
Commitments and contingencies (Notes 9 and 10)
Stockholders’ Equity:
Common stock, $0.00001 par value; 250,000,000 shares authorized; 37,815,955 and 37,488,239 shares issued as of October 31 and January 31, 2024, respectively, 37,585,955 and 37,258,239 shares outstanding as of October 31 and January 31, 2024, respectively	0	0
Additional paid-in capital	24,584	23,278
Accumulated deficit	(1,436)	(3,547)
Less: Treasury stock, 230,000 shares at cost	(150)	(150)
Total Stockholders’ Equity	22,998	19,581
Total Liabilities and Stockholders’ Equity	47,897	45,101
Series A Preferred Stock
Stockholders’ Equity:
Preferred stock value	0	0
Series B Preferred Stock
Stockholders’ Equity:
Preferred stock value	0	0
Preferred Stock
Stockholders’ Equity:
Preferred stock value	$ 0	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Unamortized debt discount	$ 25	$ 38
Preferred stock par value (in dollars per share)	$ 0.00001
Preferred stock authorized (in shares)	20,000,000
Common stock par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock authorized (in shares)	250,000,000	250,000,000
Common stock issued (in shares)	37,815,955	37,488,239
Common stock outstanding (in shares)	37,585,955	37,258,239
Treasury stock (in shares)	230,000	230,000
Series A Preferred Stock
Preferred stock par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock authorized (in shares)	120,000	120,000
Preferred stock issued (in shares)	23,400	23,400
Preferred stock outstanding (in shares)	0	0
Series B Preferred Stock
Preferred stock par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock authorized (in shares)	200,000	200,000
Preferred stock issued (in shares)	0	0
Preferred stock outstanding (in shares)	0	0
Preferred Stock
Preferred stock par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock authorized (in shares)	19,680,000	19,680,000
Preferred stock issued (in shares)	0	0
Preferred stock outstanding (in shares)	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Income Statement [Abstract]
Net sales	$ 31,523	$ 28,648	$ 89,743	$ 76,559
Costs of sales	24,410	20,013	68,288	54,047
Gross profit	7,113	8,635	21,455	22,512
Operating expenses:
Research and development	155	124	352	290
Selling, general and administrative expenses	6,395	5,804	18,155	15,297
Total operating expenses	6,550	5,928	18,507	15,587
Income from operations	563	2,707	2,948	6,925
Other income (expenses)
Interest expense	(120)	(124)	(369)	(483)
Interest income	37	0	192	0
Amortization of debt discount	(3)	(6)	(13)	(17)
Other income	61	0	61	27
Total other expenses	(25)	(130)	(129)	(473)
Net income before income tax provision and income from equity method investment	538	2,577	2,819	6,452
Income from equity method investment	0	0	0	223
Income tax expense	(128)	(568)	(708)	(1,522)
Net income	410	2,009	2,111	5,153
Less: series B preferred dividends	0	0	0	(49)
Net income available to common stockholders	$ 410	$ 2,009	$ 2,111	$ 5,104
Net income per common share
basic (in dollars per share)	$ 0.01	$ 0.05	$ 0.06	$ 0.14
diluted (in dollars per share)	$ 0.01	$ 0.05	$ 0.05	$ 0.14
Weighted average common shares outstanding
basic (in shares)	37,522	37,121	37,373	36,642
diluted (in shares)	39,442	37,646	39,261	37,088

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Total	Series A Preferred Stock	Series B Preferred Stock	Preferred Stock Series A Preferred Stock	Preferred Stock Series B Preferred Stock	Common Stock	Treasury Stock	Additional Paid In Capital	Accumulated Deficit	Accumulated Deficit Series B Preferred Stock
Beginning balance, preferred stock (in shares) at Jan. 31, 2023				0	55,000
Beginning balance at Jan. 31, 2023	$ 12,515,000			$ 0	$ 0	$ 0	$ (150,000)	$ 22,724,000	$ (10,059,000)
Beginning balance, common stock (in shares) at Jan. 31, 2023						36,318,000
Beginning balance, treasury stock (in shares) at Jan. 31, 2023							(230,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation (in shares)						19,000
Stock based compensation	270,000							270,000
Stock issued for the exercise of options and warrants (in shares)						212,000
Stock issued for the exercise of options and warrants	65,000							65,000
Issuance of shares for director settlement	0
Conversion of series B preferred stock to common stock (in shares)					(55,000)	819,000
Series B Preferred dividend			$ (49,000)							$ (49,000)
Net income	5,153,000								5,153,000
Ending balance, preferred stock (in shares) at Oct. 31, 2023				0	0
Ending balance at Oct. 31, 2023	17,954,000			$ 0	$ 0	$ 0	$ (150,000)	23,059,000	(4,955,000)
Ending balance, common stock (in shares) at Oct. 31, 2023						37,368,000
Ending balance, treasury stock (in shares) at Oct. 31, 2023							(230,000)
Beginning balance, preferred stock (in shares) at Jul. 31, 2023				0	0
Beginning balance at Jul. 31, 2023	15,798,000			$ 0	$ 0	$ 0	$ (150,000)	22,912,000	(6,964,000)
Beginning balance, common stock (in shares) at Jul. 31, 2023						37,343,000
Beginning balance, treasury stock (in shares) at Jul. 31, 2023							(230,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation	110,000							110,000
Stock issued for the exercise of options and warrants (in shares)						25,000
Stock issued for the exercise of options and warrants	37,000							37,000
Series B Preferred dividend			$ 0
Net income	2,009,000								2,009,000
Ending balance, preferred stock (in shares) at Oct. 31, 2023				0	0
Ending balance at Oct. 31, 2023	17,954,000			$ 0	$ 0	$ 0	$ (150,000)	23,059,000	(4,955,000)
Ending balance, common stock (in shares) at Oct. 31, 2023						37,368,000
Ending balance, treasury stock (in shares) at Oct. 31, 2023							(230,000)
Beginning balance, preferred stock (in shares) at Jan. 31, 2024		0	0	0	0
Beginning balance at Jan. 31, 2024	$ 19,581,000			$ 0	$ 0	$ 0	$ (150,000)	23,278,000	(3,547,000)
Beginning balance, common stock (in shares) at Jan. 31, 2024	37,258,239					37,488,000
Beginning balance, treasury stock (in shares) at Jan. 31, 2024	(230,000)						(230,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation (in shares)						222,000
Stock based compensation	$ 801,000							801,000
Stock issued for the exercise of options (in shares)	37,500					38,000
Stock issued for the exercise of options	$ 55,000							55,000
Issuance of shares for director settlement (in shares)						68,000
Issuance of shares for director settlement	450,000							450,000
Series B Preferred dividend			$ 0
Net income	2,111,000								2,111,000
Ending balance, preferred stock (in shares) at Oct. 31, 2024		0	0	0	0
Ending balance at Oct. 31, 2024	$ 22,998,000			$ 0	$ 0	$ 0	$ (150,000)	24,584,000	(1,436,000)
Ending balance, common stock (in shares) at Oct. 31, 2024	37,585,955					37,816,000
Ending balance, treasury stock (in shares) at Oct. 31, 2024	(230,000)						(230,000)
Beginning balance, preferred stock (in shares) at Jul. 31, 2024				0	0
Beginning balance at Jul. 31, 2024	$ 22,297,000			$ 0	$ 0	$ 0	$ (150,000)	24,293,000	(1,846,000)
Beginning balance, common stock (in shares) at Jul. 31, 2024						37,663,000
Beginning balance, treasury stock (in shares) at Jul. 31, 2024							(230,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation (in shares)						145,000
Stock based compensation	280,000							280,000
Stock issued for the exercise of options and warrants (in shares)						8,000
Stock issued for the exercise of options and warrants	11,000							11,000
Series B Preferred dividend			$ 0
Net income	410,000								410,000
Ending balance, preferred stock (in shares) at Oct. 31, 2024		0	0	0	0
Ending balance at Oct. 31, 2024	$ 22,998,000			$ 0	$ 0	$ 0	$ (150,000)	$ 24,584,000	$ (1,436,000)
Ending balance, common stock (in shares) at Oct. 31, 2024	37,585,955					37,816,000
Ending balance, treasury stock (in shares) at Oct. 31, 2024	(230,000)						(230,000)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 2,111	$ 5,153
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	1,057	767
Amortization of debt discount	13	17
Amortization of right of use assets	(167)	221
Amortization of intangibles	1,156	692
Stock-based compensation	801	220
Allowance for obsolete inventory	0	78
Change in deferred tax asset	90	299
Income from equity method investment	0	(223)
Changes in operating assets and liabilities:
Allowance for credit losses	0	140
Accounts receivable	(708)	(1,170)
Inventories	120	986
Prepaid expenses and other current assets	(491)	(179)
Security deposits	0	(35)
Accounts payable and accrued expenses	1,872	(1,851)
Operating lease liability	180	(237)
Net Cash Provided by Operating Activities	6,034	4,878
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(5,022)	(671)
Cash paid for investment in Chef Inspirational Foods, LLC, net	0	(646)
Net Cash (Used in) Investing Activities	(5,022)	(1,317)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of term loan	(1,274)	(1,265)
Repayment of line of credit, net	0	(890)
Repayment of related party note	(1,200)	0
Repayment of finance lease obligations	(296)	(175)
Payment of Series B Preferred dividends	0	(49)
Proceeds from exercise of stock options	55	65
Net Cash (Used in) Financing Activities	(2,715)	(2,314)
Net (Decrease) Increase in Cash	(1,703)	1,247
Cash and cash equivalents at beginning of period	11,022	4,378
Cash and cash equivalents at end of period	9,319	5,625
SUPPLEMENTARY CASH FLOW INFORMATION:
Income taxes	947	112
Interest	329	477
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of series B preferred stock to common stock	0	0
Finance lease asset additions	511	1,297
Right of use asset recognized	873	0
Write-off of right of use asset	897	0
Related party debt incurred for purchase of Chef Inspirational Foods, LLC	0	2,700
Settlement of liability in common stock	0	50
Issuance of stock for director settlement	450	0
Receipt of fixed assets for deposits previously paid	$ 937	$ 0

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	9 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Basis of Presentation	Nature of Operations and Basis of Presentation Nature of Operations Mama's Creations, Inc. (together with its subsidiaries, the “Company”, "we", "our", or "us"), (formerly known as Mama Mancini's Holdings, Inc. and Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation. The Company has a fiscal year-end of January 31. Our subsidiary MamaMancini’s Inc. (“MamaMancini's”) is a marketer, manufacturer and distributor of beef and turkey meatballs with sauce, grilled, roasted and breaded chicken, sausage and peppers, and other similar meats and sauces. In addition, the Company continues to diversify its product line by introducing new products such as ready to serve meals, single-serve pasta bowls, bulk deli, and packaged refrigerated protein products. MamaMancini's products feature many all-natural meals that were submitted to the United States Department of Agriculture (the “USDA”) and approved as "all-natural." The USDA defines "all-natural" as a product that contains no artificial ingredients, coloring ingredients or chemical preservatives and is minimally processed. Our subsidiary T&L Acquisition Corp. is a premier gourmet food manufacturer based in New York. T&L Acquisition Corp., under the brands T&L Creative Salads (“T&L”) and Olive Branch offers a full line of foods for retail food chains and club stores, delis, bagel stores, caterers and provision distributors. T&L uses high-quality meats, seafood and vegetables, prepared to meet the standards set forth by the USDA and the Food and Drug Administration ("FDA"). Olive Branch concentrates on selling olives, olive mixes, and savory products to a limited number of large retail customers, primarily in pre-packaged containers. In 2022, the Company acquired a 24% minority interest in Chef Inspirational Foods, LLC (“CIF”), a leading developer, innovator, marketer and sales company selling prepared foods, for an investment of $1.2 million. The investment consisted of $500 thousand in cash and $700 thousand in the Company’s common stock. The acquisition of the interest in CIF was accounted for under the equity method of accounting for investments until the Company acquired the remaining interest in CIF. On June 28, 2023, the Company completed the acquisition of the remaining 76% of CIF, in accordance with the terms of the Membership Interest Purchase Agreement dated June 28, 2023 by and among the Company, Siegel Suffolk Family, LLC, and R&I Loeb Family, LLC (the “Sellers”) for approximately $3.7 million, including approximately $1 million in cash at closing and a $2.7 million promissory note (the "CIF Acquisition"). The promissory note required a principal payment of $1.2 million in cash on the first anniversary of the closing date (which was made during the three months ended July 31, 2024), and requires a payment of $1.5 million in common stock of the Company on the second anniversary of the closing date. The following presents the unaudited results of operations for the period February 1, 2023 through June 28, 2023 of CIF (in thousands): For the Period Revenues $ 13,721 Net income $ 931 Name Change On July 31, 2023, the Company filed an amendment to the Articles of Incorporation with the Secretary of State of the State of Nevada to change the Company’s name from “MamaMancini’s Holdings, Inc.” to “Mama’s Creations, Inc.” (the “Name Change”). The Name Change, which was approved by the Company’s stockholders at its annual meeting on July 31, 2023, did not alter the voting powers or relative rights of the Company.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Condensed Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company’s financial position as of October 31, 2024, and the results of its operations and its cash flows for the periods presented. The unaudited Condensed Consolidated Financial Statements herein should be read together with the historical Consolidated Financial Statements of the Company for the years ended January 31, 2024 and 2023 included in our Annual Report on Form 10-K for the year ended January 31, 2024 (the "2024 Form 10-K"), as filed with the SEC on April 24, 2024. Operating results for the three and nine months ended October 31, 2024 are not necessarily indicative of the results that may be expected for the year ending January 31, 2025. Certain amounts in the prior years have been reclassified to conform to the current year presentation. Principles of Consolidation The unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances have been eliminated in consolidation. Use of Estimates The preparation of unaudited Condensed Consolidated Financial Statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited Condensed Consolidated Financial Statements and accompanying notes. Such estimates and assumptions impact, among other items, allowance for credit losses, the fair value of stock-based compensation, inventory reserves, impairment of goodwill and intangible assets, and estimates for unrealized returns, discounts, and other variable considerations that are netted against revenue. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited Condensed Consolidated Financial Statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates. Risks and Uncertainties The Company operates in an industry that is subject to intense competition and changes in consumer demand. The Company’s operations are subject to significant risks and uncertainties, including financial and operational risks, including the potential risk of business failure. The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis. Segment Reporting For the three and nine months ending October 31, 2024 and October 31, 2023, the Company was managed as a single operating segment. The Chief Executive Officer, who is the Company's Chief Operating Decision Maker ("CODM"), reviews financial information on an aggregate basis for purposes of allocating resources and assessing financial performance, as well as for making strategic operational decisions and managing the organization. As such the Company has one reportable segment. Additionally, all of the Company's assets are maintained in the United States. Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. As of October 31, 2024, the Company had approximately $8.5 million that exceeded federally insured limits. Accounts Receivable and Allowance for Credit Losses Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. Estimated product returns are immaterial. Management assesses the collectability of outstanding customer invoices and maintains an allowance resulting from the expected non-collection of customer receivables. In estimating this reserve, management considers factors such as historical collection experience, customer creditworthiness, specific customer risk, and current and expected general economic conditions. Customer balances are written off after all collection efforts are exhausted. The reserve for uncollectible accounts was approximately $93 thousand as of October 31, 2024 and January 31, 2024. During the three and nine months ended October 31, 2024 the Company did not write off any accounts deemed uncollectible. During the three and nine months ended October 31, 2023 the Company wrote off approximately $0 and $140 thousand of uncollectible accounts respectively. Inventories The Company values its inventory at the lower of cost or net realizable value (“NRV”). NRV is defined as estimated selling prices less costs of completion, disposal, and transportation. The cost of inventory is determined on the first-in, first-out basis. The cost of finished goods inventories includes ingredients, direct labor, freight-in for ingredients, and indirect production and overhead costs. The Company monitors its inventory to identify excess or obsolete items on hand. The Company reviews inventory quantities on hand and records a provision for excess and obsolete inventory based primarily on selling prices and indications from customers based upon current price negotiations and purchase orders. In addition, and as necessary, specific reserves for future known or anticipated events may be established. As of October 31, 2024 and January 31, 2024, the reserve for obsolete inventory was approximately $95 thousand. Inventories by major category are as follows (in thousands): October 31, 2024 January 31, 2024 Raw materials and packaging $ 1,316 $ 1,159 Work in process 330 237 Finished goods 1,544 1,914 Total $ 3,190 $ 3,310 Property, Plant and Equipment Property, plant, and equipment are recorded at cost net of depreciation. Depreciation expense is computed using straight-line methods over the estimated useful lives. Asset lives for financial statement reporting of depreciation expense are: Machinery and equipment 2-7 years Furniture and fixtures 3-5 years Leasehold improvements * (*) Amortized on a straight-line basis over the shorter of the remaining lease term at the time the assets were placed in service or their estimated useful lives. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts, and any gain or loss is reflected in the condensed consolidated statements of operations. Goodwill and Other Intangible Assets Goodwill Goodwill represents the excess of the purchase price over the fair values of the underlying net assets of an acquired business. The Company tests goodwill for impairment on an annual basis during the fourth quarter of its fiscal year, or immediately if conditions indicate that an impairment could exist. The Company evaluates qualitative factors to determine if it is more likely than not that the fair value is less than its carrying value and whether it is necessary to perform goodwill impairment testing. As of October 31, 2024 and January 31, 2024, there were no impairment losses recognized for goodwill. Other Intangible Assets Other intangible assets consist of trademarks, trade names and customer relationships. Intangible asset lives for financial statement reporting of amortization are: Tradenames and trademarks 3 years Customer relationships 4 – 5 years Fair Value of Financial Instruments The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short-term financial instruments approximates fair value due to the relatively short period to maturity for these instruments. Research and Development Research and development is expensed as incurred. Research and development expenses were $155 thousand and $352 thousand for the three and nine months ended October 31, 2024, respectively, compared to $124 thousand and $290 thousand for the three and nine months ended October 31, 2023, respectively. Revenue Recognition The Company recognizes revenue in accordance with FASB Topic 606, Revenue from Contracts with Customers (Topic 606). The Company’s sales are primarily generated from the sale of finished products to customers. Revenue is recognized when the performance obligation is satisfied, and the promised goods have been transferred. Control transfers when the product is shipped or delivered based upon applicable shipping terms. For each contract, the Company considers the transfer of product to be the performance obligation. Although some payment terms may be extended, generally the Company’s payment terms are approximately 15- 30 days. Accordingly, there are no significant financing components to consider when determining the transaction price. The Company elected to treat shipping and handling activities as fulfillment activities, and the related costs are recorded as selling expenses in selling, general and administrative expenses on the Condensed Consolidated Statements of Operations. The Company promotes its products with trade incentives and promotions. These programs include discounts, slotting fees, coupons, rebates, in-store display incentives and volume-based incentives. The trade incentives and promotions are recorded as a reduction to the transaction price based on amounts estimated as being due to customers at the end of the period. The Company derives these estimates based on historical experience. The Company does not receive a distinct service in relation to the trade incentives and promotions. The Company’s contracts are all short term in nature; therefore, there are no unsatisfied performance obligations requiring disclosure as of October 31, 2024 and January 31, 2024. Expenses such as slotting fees, sales discounts, and variable considerations are accounted for as a direct reduction of revenues as follows (in thousands): For the Three Months Ended October 31, 2024 October 31, 2023 Gross Sales $ 32,333 $ 29,294 Less: Trade Incentives and Promotions 810 646 Net Sales $ 31,523 $ 28,648 For the Nine Months Ended October 31, 2024 October 31, 2023 Gross Sales $ 91,435 $ 78,309 Less: Trade Incentives and Promotions 1,692 1,750 Net Sales $ 89,743 $ 76,559 Disaggregation of Revenue from Contracts with Customers. The following table disaggregates gross revenue by significant geographic area for the three months ended October 31, 2024 and 2023 (in thousands): For the Three Months Ended October 31, 2024 October 31, 2023 Northeast $ 8,277 $ 9,317 Southeast 8,763 8,225 Midwest 7,049 6,116 West 8,244 5,636 Total gross sales $ 32,333 $ 29,294 For the Nine Months Ended October 31, 2024 October 31, 2023 Northeast $ 26,534 $ 27,267 Southeast 24,470 22,113 Midwest 19,201 14,371 West 21,230 14,558 Total gross sales $ 91,435 $ 78,309 Costs of Sales Costs of sales represents costs directly related to the production and manufacturing of the Company’s products. Advertising Costs incurred for advertising for the Company are charged to selling, general and administrative expenses as incurred. Advertising expenses wer e $663 thousand and $1,480 thousand fo r the three and nine months ended October 31, 2024, respectively, compared to $380 thousand and $779 thousand for the three and nine months ended October 31, 2023, respectively. Stock-Based Compensation The Company provides compensation benefits in the form of performance stock awards, restricted stock units, stock options, and warrants. The cost of the stock-based compensation is recorded at fair value on the date of grant and expensed in the Condensed Consolidated Statement of Operations over the requisite service period. The Company has granted performance stock awards ("PSUs") to certain executive officers. Each performance stock award entitles the participant to earn shares of common stock upon the attainment of certain market conditions and/or certain performance goals over the applicable performance period. The recognition of the compensation expense for the performance stock awards is based upon the probable outcome of the market condition and performance conditions based on the fair value of the award on the date of grant. To determine the value of PSUs with market conditions for stock-based compensation purposes, the Company used a Monte Carlo simulation valuation model. For each path, the PSUs' payoff is calculated based on the contractual terms, whereas the fair value of the PSUs is calculated as the average present value of all modeled payoffs. The determination of the grant date fair value of PSUs issued is affected by a number of variables and subjective assumptions, including (i) the fair value of the Company’s common stock at the grant date of $1.17 and $1.40, (ii) the expected common stock price volatility over the expected life of the award of 85.7% and 87.0%, (iii) the term of the awards of 5 years and 5 years, (iv) the risk-free interest rate of 3.7% and 3.4%, and (v) the expected dividend yield of 0% and 0%. Forfeitures are recognized when they occur. There were no performance stock units that vested in the three and nine months ending October 31, 2024. T he Company's performance against the defined goals is re-evaluated on a quarterly basis throughout the performance period and the recognition of the compensation expense is adjusted for subsequent changes in the estimated or actual outcome. The Company values stock options and warrants using the Black-Scholes option pricing model. Grants of stock-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the stock-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service period, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. The Company values Restricted Stock Units ("RSUs") at the closing stock price on the date of the grant. Earnings Per Share Basic net income or loss per share attributable to common stockholders excludes dilution and is computed by dividing net income attributable to common stockholders during the period by the weighted average number of common shares outstanding during the period. Diluted net income or loss per share reflects potential dilution and is computed by dividing net income attributable to common stockholders by the weighted average number of common shares outstanding during the period, which is increased by the number of additional common shares that would have been outstanding if the potential common shares had been issued. However, if the effect of any additional securities are anti-dilutive (i.e., resulting in a higher net income per share or lower net loss per share), they are excluded from the dilutive earnings per share computation. The dilutive effect of stock options, warrants, and restricted stock is calculated using the treasury stock method, and the dilutive effect of the Series B Preferred stock and PSUs is calculated using the if-converted method. The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income attributable to common stockholders per common share (in thousands, except per share data): For the Three Months Ended October 31, 2024 October 31, 2023 Numerator: Net income attributable to common stockholders $ 410 2,009 Effect of dilutive securities: — — Diluted net income $ 410 $ 2,009 Denominator: Weighted average common shares outstanding – basic 37,522 37,121 Dilutive securities (a): Restricted stock 266 447 Performance stock awards 1,600 — Options 54 78 Weighted average common shares outstanding and assumed conversion – diluted 39,442 37,646 Basic net income per common share $ 0.01 $ 0.05 Diluted net income per common share $ 0.01 $ 0.05 (a) – Anti-dilutive securities excluded — — For the Nine Months Ended October 31, 2024 October 31, 2023 Numerator: Net income attributable to common stockholders $ 2,111 $ 5,104 Effect of dilutive securities: — 49 Diluted net income $ 2,111 $ 5,153 Denominator: Weighted average common shares outstanding – basic 37,373 36,642 Dilutive securities (a): Restricted stock 238 384 Options 50 62 Performance stock awards 1,600 — Weighted average common shares outstanding and assumed conversion – diluted 39,261 37,088 Basic net income per common share $ 0.06 $ 0.14 Diluted net income per common share $ 0.05 $ 0.14 (a) – Anti-dilutive securities excluded — — Income Taxes Income taxes are provided in accordance with ASC 740, “ Accounting for Income Taxes. ” A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense results from the net change during the period of deferred tax assets and liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets are adjusted for the effects of changes in tax laws and rates on the date of enactment. As of October 31, 2024 and January 31, 2024, the Company recognized a deferred tax asset of $413 thousand and $503 thousand, respectively, which is included in other long-term assets on the Condensed Consolidated Balance Sheets. The Company regularly evaluates the need for a valuation allowance related to the deferred tax asset. Recent Accounting Pronouncements In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies an issuer’s accounting for convertible instruments by reducing the number of accounting models that require separate accounting for embedded conversion features. ASU 2020-06 also simplifies the settlement assessment that entities are required to perform to determine whether a contract qualifies for equity classification and makes targeted improvements to the disclosures for convertible instruments and earnings per share (EPS) guidance. This update was effective for the Company’s fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. In March 2023, the FASB issued ASU No. 2023-02, "Investments - Equity Method and Joint Ventures (Topic 323): Accounting for Investment Tax Credit Structures Using the Proportional Amortization Method." The amendments in this update permit reporting entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. This guidance was effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. In October 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-06, "Disclosure Improvements: Amendments - Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative." The FASB issued the standard to introduce changes to U.S. GAAP that originate in either SEC Regulation S-X or S-K, which are rules about the form and content of financial reports. The provisions of the standard are contingent when the SEC removes the related disclosure provisions from Regulation S-X and S-K. The Company does not expect the provisions of the standard to have a material impact on the Company's financial statements and related disclosures. In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The new guidance is intended to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendment is effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company is in the process of evaluating the impact that the adoption ASU No. 2023-07 will have to the financial statements and related disclosures. In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." The new guidance is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in the ASU address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. The amendment is effective retrospectively for fiscal years beginning after December 15, 2024, on a prospective basis, with early adoption permitted. The Company is in the process of evaluating the impact that the adoption of ASU No. 2023-09 will have to the financial statements and related disclosures. Management does not believe that any recently issued but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying condensed consolidated financial statements. Fair Value Measurements Assets and liabilities recorded at fair value are measured using the fair value hierarchy, which prioritizes the inputs used in measuring fair value. The levels of the fair value hierarchy are: Level 1: observable inputs such as quoted prices in active markets; Level 2: inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: unobservable inputs for which little or no market data exists, therefore requiring the Company to develop its own assumptions. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company's financial assets that were accounted for at fair value on a recurring basis as of October 31, 2024 and January 31, 2024 were as follows (in thousands): October 31, 2024 January 31, 2024 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents $ 9,168 $ — $ — $ 9,168 $ 10,912 $ — $ — $ 10,912 Total $ 9,168 $ — $ — $ 9,168 $ 10,912 $ — $ — $ 10,912

Property Plant and Equipment, N

Property Plant and Equipment, Net:	9 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Property Plant and Equipment, Net:	Property Plant and Equipment, Net: Property plant and equipment, net on October 31, 2024 and January 31, 2024 were as follows (in thousands): October 31, 2024 January 31, 2024 Machinery and Equipment $ 7,948 $ 4,437 Furniture and Fixtures 242 252 Leasehold Improvements 5,848 2,956 14,038 7,645 Less: Accumulated Depreciation 4,189 3,209 Total $ 9,849 $ 4,436

Intangible Assets, Net

Intangible Assets, Net	9 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Intangible Assets, Net Intangible assets, net, consisted of the following at October 31, 2024 (dollars in thousands): Gross Accumulated Net Carrying Weighted Customer relationships $ 6,418 $ (2,600) $ 3,818 2.55 Tradename and trademarks 79 (75) 4 0.16 Total intangible assets $ 6,497 $ (2,675) $ 3,822 Intangible assets, net consisted of the following at January 31, 2024 (dollars in thousands): Gross Accumulated Net Carrying Weighted Customer relationships $ 6,418 $ (1,463) $ 4,955 3.29 Tradename and trademarks 79 (55) 24 0.91 Total intangible assets $ 6,497 $ (1,518) $ 4,979 Amortization expense was approximately $388 thousand and $1.2 million for the three and nine months ended October 31, 2024, respectively, compared to approximately $388 thousand and $692 thousand for the three and nine months ended October 31, 2023, respectively. We expect the estimated aggregate amortization expense for each of the four succeeding fiscal years to be as follows (in thousands): 2025 (Remaining) $ 382 2026 1,513 2027 1,465 2028 462 Total $ 3,822

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Promissory Notes – Related Parties Upon consummation of the acquisition of T&L in December 2021, the Company executed a $3 million promissory note with the sellers. The promissory note requires annual principal payments of $750 thousand, payable on each anniversary of the closing, together with accrued interest at a rate of three and one-half percent (3.5%) per annum. As of both October 31, and January 31, 2024, the outstanding balance under the note was $1.5 million, of which $750 thousand was recorded as Promissory notes – related parties and $750 thousand is recorded as Promissory notes – related parties, net of current, in the Company’s Condensed Consolidated Balance Sheets. Interest expense related to this note was approximately $14 thousand and $40 thousand for the three and nine months ended October 31, 2024, respectively, compared to approximately $20 thousand and $39 thousand for the three and nine months ended October 31, 2023, respectively. As of October 31, 2024 and January 31, 2024, accrued interest was approximately $44 thousand and $5 thousand, respectively. Lease – Related Party The Company leases a fully contained facility in Farmingdale, NY from 148 Allen Blvd LLC for production and distribution of T&L Creative Salads and Olive Branch products. 148 Allen Blvd LLC is owned by Anthony Morello, Jr., President of T&L, and various individuals related to Mr. Morello. This lease term is through November 30, 2031 with the option to extend the lease for two additional ten-year terms with base rent of approximately $20 thousand per month through December 31, 2026, increasing after that date to approximately $24 thousand per month through the end of the initial lease term. The exercise of optional renewal is uncertain and therefore excluded from the calculation of the right of use asset. Rent expense and other ancillary charges pursuant to the lease for the three and nine months ended October 31, 2024 were approximately $81 thousand and $240 thousand, respectively, compared to $96 thousand and $267 thousand for the three and nine months ending October 31, 2023. Chef Inspirational Foods, LLC – Related Party The Company owned a 24% minority interest in CIF until June 28, 2023, when the Company acquired the remaining interest (refer to Note 1). For the period from February 1, 2023 to June 28, 2023, the Company recorded sales of approximatel y $10.9 million with CIF

Loan and Security Agreements

Loan and Security Agreements	9 Months Ended
	Oct. 31, 2024
Loan And Security Agreements
Loan and Security Agreements	Loan and Security Agreements M&T Bank The Company has a working capital line of credit with M&T Bank for a maximum principal amount of $5.5 million (the "Credit Agreement") . On July 31, 2024 , the Company extended the maturity date of the working capital line from October 31, 2025 to November 30, 2027 . The principal outstanding bears interest at a variable rate per annum based on the Company’s Senior Funded Debt/EBITDA Ratio (as defined in the Credit Agreement), established with respect to the Borrower as of the date of any advance under the Credit Agreement as follows: if the Senior Funded Debt/EBITDA ratio is: (i) greater than 2.25, 3.25 percentage point(s) above the applicable one-day (i.e. overnight) SOFR (as defined); (ii) greater than 1.50 but less than 2.25, 2.75 percentage points above the one-day SOFR; (iii) less than or equal to 1.50, 2.25 percentage points above the one-day SOFR. The facility is supported by a first priority security interest in all of the Company’s business assets and is further subject to various affirmative and negative financial covenants. The Company was in compliance with the covenants as of October 31, 2024 and January 31, 2024. Advances under the line of credit are limited to eighty percent (80%) of eligible accounts receivable (which is subject to an agreed limitation and is further subject to certain asset concentration provisions) and fifty percent (50%) of eligible inventory (which is subject to an agreed dollar limitation). All advances under the line of credit are due upon maturity. There was no outstanding balance on the line of credit as of October 31, or January 31, 2024. During the three and nine months ended October 31, 2024 the Company incurred no interest, compared to approximately $1 thousand and $47 thousand for the three and nine months ended October 31, 2023, respectively. On December 29, 2021, the Com pany entered into a loan with M&T Bank for the original principal amount of $7.5 million payable in equal monthly principal installments over a 60-month amortization period (the “Acquisition Note”). The Maturity Date of the Acquisition Note is January 17, 2027. The Acquisition Note was amended effective December 4, 2023, to change the rate at which interest accrues and amended on July 31, 2024 to amend certain covenants. Effective December 4, 2023 the interest rate was amended to be based on the Senior Funded Debt/EBITDA Ratio (as defined in the Acquisition Note). If the Senior Funded Debt/EBITDA ratio is: (i) greater than 2.25, 3.5 percentage point(s) above the applicable Variable Loan Rate; (ii) greater than 1.50 but less than or equal to 2.25, 3.0 percentage points of the applicable Variable Loan Rate; or (iii) less than or equal to 1.50, 2.5 percentage points above the applicable Variable Loan Rate; provided that in all events the rate shall not be less than the recited percentage point margin over 0%. As of October 31, 2024 , the outstanding balance and unamortized discount of the Acquisition Note were approximately $3.3 million and $25 thousand, respectively. As of January 31, 2024

Concentrations

Concentrations	9 Months Ended
	Oct. 31, 2024
Risks and Uncertainties [Abstract]
Concentrations	Concentrations Revenues For the three months ended October 31, 2024, the Company’s revenue was concentrated in two customers that accounted for approximately 43% and 10% of gross revenue, respectively. For the nine months ended October 31, 2024, the Company’s revenue was concentrated in one customer that accounted for approximately 41% of gross revenue. For the three months ended October 31, 2023, the Company’s revenue was concentrated in two customers that accounted for approximately 39% and 12% of gross revenue, respectively. For the nine months ended October 31, 2023, the Company’s revenue was concentrated in three customers that accounted for approximately 22%, 14%, and 11% of gross revenue, respectively. Receivables As of October 31, 2024, two customers represented approximately 35% and 17% of the total gross outstanding receivables, respectively. As of January 31, 2024, four customers represented approximately 20%, 15%, 13%, and 10% of total gross outstanding receivables, respectively.

Stockholders_ Equity

Stockholders’ Equity	9 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Stockholders’ Equity	Stockholders’ Equity Preferred Stock and Series A Preferred Stock The Company is authorized to issue 20 million shares of Preferred Stock, $0.00001 par value per share. The Company has designated 120 thousand shares of Preferred Stock as Series A Convertible Preferred stock. As of October 31, 2024 and January 31, 2024, no shares of Series A Convertible Preferred Stock were outstanding. Series B Preferred Stock The Company has designated 200 thousand shares of preferred stock, Series B Preferred Stock. As of October 31, 2024 and January 31, 2024, no shares of Series B Preferred Stock remain outstanding. The holders of the Series B Preferred Stock were entitled to receive, upon liquidation, dissolution or winding up of the Company, the original issue price, plus any dividends declared but unpaid or the amount of cash, securities or other property to which such holder would be entitled to receive with respect to such shares of Series B Preferred Stock if such shares had been converted to common stock immediately prior to such liquidation. Holders of the Series B Preferred Stock were entitled to receive cumulative cash dividends at an annual rate of eight percent (8%). Holders of the Series B Preferred Stock had no voting rights. Each share of Series B Preferred Stock was convertible, at the option of the holder, into shares of common stock at a rate of 1 share of Series B Preferred Stock into 15 shares of common stock. The Company was able to force conversion at $2.00 per share of Common Stock at any time after 6 months after issue if the Common Stock had a closing price of $2.00 or higher in any 20 consecutive trading days. After 18 months, the Company could force holders to convert at a 20% discount to the most recent 20-day average closing price per share. The Company also had the right to cause a conversion following a Fundamental Change. On June 22, 2023, all the holders of the Series B Preferred Stock converted the shares of Series B Preferred Stock into 819,000 shares of Common Stock of the Company. The Company paid dividends of approximately $0 thousand and $49 thousand for the three and nine months ended October 31, 2023, respectively. Such dividends related to the Company's then outstanding Series B Preferred Stock. Because no shares of Series B Preferred Stock were outstanding, no such dividends were paid during the three and nine months ended October 31, 2024. Restricted Stock Units The fair value of RSUs is determined based on the closing price of the Company's Common Stock on the grant date. RSUs generally vest on a graded basis over three years to four years of service. The terms of the RSUs include vesting provisions based solely on continued service. The following is a summary of the Company’s restricted stock units activity: Restricted Weighted Average Grant Date Fair Value Non-vested restricted stock units - February 1, 2024 493,078 $ 1.91 Granted 97,026 $ 7.16 Vested (219,776) $ 2.61 Forfeited - $ - Outstanding – October 31, 2024 370,328 $ 2.87 During the three and nine months ended October 31, 2024, the Company recognized stock-based compensation expense related to restricted stock units of an aggregate of approximately $136 thousand and $447 thousand, respectively, compared to $167 thousand and $98 thousand for the three and nine months ended October 31, 2023, respectively. The restricted stock expense was recorded to selling, general and administrative expenses or cost of goods sold depending on the nature of the employee's expense on the Condensed Consolidated Statement of Operations. As of October 31, 2024, there was unrecognized stock-based compensation of approximately $996 thousand related to future vesting of restricted stock units. Options The following is a summary of the Company’s option activity: Options Weighted Average Weighted Aggregate Intrinsic Value Outstanding – February 1, 2024 117,500 $ 1.48 8.36 $ 333 Granted 38,806 $ 7.57 Exercised (37,500) $ 1.48 Expired/forfeited (15,000) $ 1.48 Outstanding – October 31, 2024 103,806 $ 3.76 8.47 $ 388 Exercisable – October 31, 2024 0 $ — 0.00 $ — During the nine months ended October 31, 2024, there were 37,500 options exercised at a weighted average exercise price of $1.48 per share resulting in the issuance of approximately 38 thousand shares of common stock. The Company received approximately $55 thousand for the exercise of these options. During the nine months ended October 31, 2024 the Company granted options to purchase 38,806 shares. The Company values stock options using the Black-Scholes option pricing model. The grants are amortized on a straight-line basis over the requisite service period, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. For the nine months ended October 31, 2024, when computing the fair value of the stock options issued, the Company used the following variables: (i) risk-free interest rate of 3.5% , (ii) expected term of the award of 6 years, (iii) expected volatility of the underlying stock of 76%, and (iv) no expected dividend yield. For the three and nine months ended October 31, 2024, the Company recognized stock-based compensation expense related to options of an aggregate of approximately $16 thousand and $23 thousand, respectively, compared to $12 thousand and $53 thousand for the three and nine months ended October 31, 2023. The stock-based compensation expense related to the options is included in selling, general and administrative expenses on the accompanying Condensed Consolidated Statements of Operations. During the nine months ended October 31, 2024, certain employees and contractors resigned from the Company, which resulted in the reversal of approximately $11 thousand of previously recognized stock-based compensation expense. At October 31, 2024, there was unrecognized stock-based compensation expense related to the issuance of options of approximately $213 thousand. Performance Stock Units During the year ended January 31, 2023, the Company issued certain PSUs to the Chief Executive Officer and Chief Financial Officer based on certain market and performance conditions of the Company compared to the respective targets. During the three and nine ended October 31, 2024, the Company issued PSUs to the Chief Operating Officer depending on the Company's Earnings per Share compared to respective targets. During the three and nine months ended October 31, 2024, the Company recognized stock-based compensation expense related to PSUs of approximately $91 thousand and $311 thousand, respectively. The stock-based compensation expense related to the PSUs is included in selling, general and administrative expenses on the accompanying Condensed Consolidated Statements of Operations. Equity issuances On May 15, 2024, the Company entered into a Settlement Agreement with directors Alfred D’Agostino, Steven Burns, Dean Janeway and Thomas Toto (each, a “Director”), relating to certain options purported to have been granted by the Company in 2018 and 2019 (the "Purported Options") under prior management that exceeded the availability under the Company’s equity plan at the time of the purported grants. In exchange for a release of any and all claims or rights related to the Purported Options, the Company agreed to issue each Director a payment of approximately $113 thousand and approximately 17 thousand shares of common stock. In connection with the Settlement Agreement and the issuance of the shares, the Company incurred a one-time charge of approximately $900 thousand within selling, general and administrative expense in the three months ended April 30, 2024. During the three and nine months ended October 31, 2024, t he Company is sued 3,007 shares valued at approximately $20 thousand to certain employees as compensation.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation, Claims and Assessments From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. Licensing and Royalty Agreements On March 1, 2010, the Company was assigned a Development and License agreement, dated January 1, 2009, with Daniel Dougherty (the “License Agreement”). Under the terms of the License Agreement, the royalty rate payable by the Company is 6% of net sales up to $500 thousand of net sales (as defined in the agreement) for each year under the License Agreement; 4% of net sales from $500 thousand up to $2.5 million of net sales for each year under the License Agreement; 2% of net sales from $2.5 million up to $20 million of net sales for each year under the License Agreement; and 1% of net sales in excess of $20 million of net sales for each year under the License Agreement. In order to continue exclusivity, the Company must pay a minimum royalty of $125,000 each year. The Company incurred approximately $143 thousand and $448 thousand of royalty expenses for the three and nine months ended October 31, 2024, respectively, compared to $119 thousand and $437 thousand for the three and nine months ended October 31, 2023, respectively. Royalty expenses are included in selling, general and administrative expenses on the Condensed Consolidated Statements of Operations.

Leases

Leases	9 Months Ended
	Oct. 31, 2024
Leases [Abstract]
Leases	Leases The Company accounts for leases in accordance with ASC 842 “ Leases ” (“ASC 842”). We determine whether an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. In April 2024, the Company's lease of additional warehouse and office space in Farmingdale, New York became effective. The lease agreement has a five-year term with monthly rent of approximately $16.7 thousand for the first year, increasing to approximately $17.2 thousand for the second year, increasing to approximately $17.7 thousand for the third year, increasing to approximately $18.2 thousand for the fourth year and increasing to approximately $18.8 thousand for the fifth year. As a result of this lease the Company recognized a ROU)asset and a lease liability of approximately $873 thousand. During the nine months ended October 31, 2024, the Company amended and subsequently extended its lease for 25 Branca Road, East Rutherford, NJ. The amended lease had a termination date of August 31, 2024. With the initial amendment of the lease the Company wrote off approximately $897 thousand of the ROU asset and ROU liability in the nine months ended October 31, 2024. On August 21, 2024, the Company amended its lease at 25 Branca Road. The amended lease has monthly rent of approximately $36 thousand until February 28, 2026, with a renewal option to extend the lease until August 31, 2029. The monthly rent during the renewal option ranges from approximately $38 thousand to approximately $42 thousand. As a result of this lease the Company recognized a ROU asset and a lease liability of approximately $615 thousand. We have operating leases for offices and other facilities used for our operations. We also have finance leases consisting primarily of machinery and equipment. Our leases have remaining lease terms of approximately 0.50 years to 7.1 years. Supplemental cash flow and other information related to leases was as follows (in thousands): October 31, 2024 October 31, 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ (180) $ 237 Financing cash flows from finance leases 296 175 The following table shows the weighted average lease term and weighted average discount rate for our ROU lease assets: October 31, 2024 January 31, 2024 Weighted average remaining lease term (in years) Operating leases 5.20 6.57 Finance leases 4.70 4.49 Weighted average discount rate: Operating leases 5.82 % 4.85 % Finance leases 7.65 % 6.74 % Maturities of lease liabilities for each of the succeeding fiscal years are as follows (in thousands): For the fiscal years ended Finance Leases Operating Leases Total Maturities of Lease Liabilities 2025 remaining $ 132 $ 249 $ 381 2026 454 1,002 1,456 2027 406 503 909 2028 398 500 898 2029 302 507 809 Thereafter 293 839 1,132 Total undiscounted future lease payments 1,985 3,600 5,585 Less: imputed interest (341) (447) (788) Total present value of future lease liabilities $ 1,644 $ 3,153 $ 4,797
Leases	Leases The Company accounts for leases in accordance with ASC 842 “ Leases ” (“ASC 842”). We determine whether an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. In April 2024, the Company's lease of additional warehouse and office space in Farmingdale, New York became effective. The lease agreement has a five-year term with monthly rent of approximately $16.7 thousand for the first year, increasing to approximately $17.2 thousand for the second year, increasing to approximately $17.7 thousand for the third year, increasing to approximately $18.2 thousand for the fourth year and increasing to approximately $18.8 thousand for the fifth year. As a result of this lease the Company recognized a ROU)asset and a lease liability of approximately $873 thousand. During the nine months ended October 31, 2024, the Company amended and subsequently extended its lease for 25 Branca Road, East Rutherford, NJ. The amended lease had a termination date of August 31, 2024. With the initial amendment of the lease the Company wrote off approximately $897 thousand of the ROU asset and ROU liability in the nine months ended October 31, 2024. On August 21, 2024, the Company amended its lease at 25 Branca Road. The amended lease has monthly rent of approximately $36 thousand until February 28, 2026, with a renewal option to extend the lease until August 31, 2029. The monthly rent during the renewal option ranges from approximately $38 thousand to approximately $42 thousand. As a result of this lease the Company recognized a ROU asset and a lease liability of approximately $615 thousand. We have operating leases for offices and other facilities used for our operations. We also have finance leases consisting primarily of machinery and equipment. Our leases have remaining lease terms of approximately 0.50 years to 7.1 years. Supplemental cash flow and other information related to leases was as follows (in thousands): October 31, 2024 October 31, 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ (180) $ 237 Financing cash flows from finance leases 296 175 The following table shows the weighted average lease term and weighted average discount rate for our ROU lease assets: October 31, 2024 January 31, 2024 Weighted average remaining lease term (in years) Operating leases 5.20 6.57 Finance leases 4.70 4.49 Weighted average discount rate: Operating leases 5.82 % 4.85 % Finance leases 7.65 % 6.74 % Maturities of lease liabilities for each of the succeeding fiscal years are as follows (in thousands): For the fiscal years ended Finance Leases Operating Leases Total Maturities of Lease Liabilities 2025 remaining $ 132 $ 249 $ 381 2026 454 1,002 1,456 2027 406 503 909 2028 398 500 898 2029 302 507 809 Thereafter 293 839 1,132 Total undiscounted future lease payments 1,985 3,600 5,585 Less: imputed interest (341) (447) (788) Total present value of future lease liabilities $ 1,644 $ 3,153 $ 4,797

Income Tax Provision

Income Tax Provision	9 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
Income Tax Provision	Income Tax Provision The Company’s effective tax rate for the three and nine months ending October 31, 2024 and October 31, 2023 is 23.8% and 25.1%, respectively. Differences from the statutory rate primarily relate to state taxes. As of October 31, 2024, the net deferred tax asset was approximately $413 thousand. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon future generation of taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. There was no valuation allowance on the Company's deferred tax assets as of October 31, 2024 or January 31, 2024. The Company evaluated the provisions of ASC 740 related to the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740 prescribes a comprehensive model for how a company should recognize, present, and disclose uncertain positions that the Company has taken or expects to take in its tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the net benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits.” A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable is reduced) for unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Pay vs Performance Disclosure
Net income	$ 410	$ 2,009	$ 2,111	$ 5,153

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Condensed Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company’s financial position as of October 31, 2024, and the results of its operations and its cash flows for the periods presented. The unaudited Condensed Consolidated Financial Statements herein should be read together with the historical Consolidated Financial Statements of the Company for the years ended January 31, 2024 and 2023 included in our Annual Report on Form 10-K for the year ended January 31, 2024 (the "2024 Form 10-K"), as filed with the SEC on April 24, 2024. Operating results for the three and nine months ended October 31, 2024 are not necessarily indicative of the results that may be expected for the year ending January 31, 2025. Certain amounts in the prior years have been reclassified to conform to the current year presentation.
Principles of Consolidation	Principles of Consolidation The unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of unaudited Condensed Consolidated Financial Statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited Condensed Consolidated Financial Statements and accompanying notes. Such estimates and assumptions impact, among other items, allowance for credit losses, the fair value of stock-based compensation, inventory reserves, impairment of goodwill and intangible assets, and estimates for unrealized returns, discounts, and other variable considerations that are netted against revenue. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited Condensed Consolidated Financial Statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.
Risks and Uncertainties	Risks and Uncertainties The Company operates in an industry that is subject to intense competition and changes in consumer demand. The Company’s operations are subject to significant risks and uncertainties, including financial and operational risks, including the potential risk of business failure. The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.
Segment Reporting	Segment Reporting For the three and nine months ending October 31, 2024 and October 31, 2023, the Company was managed as a single operating segment. The Chief Executive Officer, who is the Company's Chief Operating Decision Maker ("CODM"), reviews financial information on an aggregate basis for purposes of allocating resources and assessing financial performance, as well as for making strategic operational decisions and managing the organization. As such the Company has one reportable segment. Additionally, all of the Company's assets are maintained in the United States.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. As of October 31, 2024, the Company had approximately $8.5 million that exceeded federally insured limits.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses
Inventories	Inventories
Property, Plant and Equipment	Property, Plant and Equipment Property, plant, and equipment are recorded at cost net of depreciation. Depreciation expense is computed using straight-line methods over the estimated useful lives. Asset lives for financial statement reporting of depreciation expense are: Machinery and equipment 2-7 years Furniture and fixtures 3-5 years Leasehold improvements * (*) Amortized on a straight-line basis over the shorter of the remaining lease term at the time the assets were placed in service or their estimated useful lives. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts, and any gain or loss is reflected in the condensed consolidated statements of operations.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill Goodwill represents the excess of the purchase price over the fair values of the underlying net assets of an acquired business. The Company tests goodwill for impairment on an annual basis during the fourth quarter of its fiscal year, or immediately if conditions indicate that an impairment could exist. The Company evaluates qualitative factors to determine if it is more likely than not that the fair value is less than its carrying value and whether it is necessary to perform goodwill impairment testing.
Fair Value of Financial Instruments and Measurements	Fair Value of Financial Instruments The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short-term financial instruments approximates fair value due to the relatively short period to maturity for these instruments. Fair Value Measurements Assets and liabilities recorded at fair value are measured using the fair value hierarchy, which prioritizes the inputs used in measuring fair value. The levels of the fair value hierarchy are: Level 1: observable inputs such as quoted prices in active markets; Level 2: inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: unobservable inputs for which little or no market data exists, therefore requiring the Company to develop its own assumptions.
Research and Development	Research and Development
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with FASB Topic 606, Revenue from Contracts with Customers (Topic 606). The Company’s sales are primarily generated from the sale of finished products to customers. Revenue is recognized when the performance obligation is satisfied, and the promised goods have been transferred. Control transfers when the product is shipped or delivered based upon applicable shipping terms. For each contract, the Company considers the transfer of product to be the performance obligation. Although some payment terms may be extended, generally the Company’s payment terms are approximately 15- 30 days. Accordingly, there are no significant financing components to consider when determining the transaction price. The Company elected to treat shipping and handling activities as fulfillment activities, and the related costs are recorded as selling expenses in selling, general and administrative expenses on the Condensed Consolidated Statements of Operations. The Company promotes its products with trade incentives and promotions. These programs include discounts, slotting fees, coupons, rebates, in-store display incentives and volume-based incentives. The trade incentives and promotions are recorded as a reduction to the transaction price based on amounts estimated as being due to customers at the end of the period. The Company derives these estimates based on historical experience. The Company does not receive a distinct service in relation to the trade incentives and promotions. The Company’s contracts are all short term in nature; therefore, there are no unsatisfied performance obligations requiring disclosure as of October 31, 2024 and January 31, 2024.
Costs of Sales	Costs of Sales Costs of sales represents costs directly related to the production and manufacturing of the Company’s products.
Advertising	Advertising
Stock-Based Compensation	Stock-Based Compensation The Company provides compensation benefits in the form of performance stock awards, restricted stock units, stock options, and warrants. The cost of the stock-based compensation is recorded at fair value on the date of grant and expensed in the Condensed Consolidated Statement of Operations over the requisite service period. The Company has granted performance stock awards ("PSUs") to certain executive officers. Each performance stock award entitles the participant to earn shares of common stock upon the attainment of certain market conditions and/or certain performance goals over the applicable performance period. The recognition of the compensation expense for the performance stock awards is based upon the probable outcome of the market condition and performance conditions based on the fair value of the award on the date of grant. To determine the value of PSUs with market conditions for stock-based compensation purposes, the Company used a Monte Carlo simulation valuation model. For each path, the PSUs' payoff is calculated based on the contractual terms, whereas the fair value of the PSUs is calculated as the average present value of all modeled payoffs. The determination of the grant date fair value of PSUs issued is affected by a number of variables and subjective assumptions, including (i) the fair value of the Company’s common stock at the grant date of $1.17 and $1.40, (ii) the expected common stock price volatility over the expected life of the award of 85.7% and 87.0%, (iii) the term of the awards of 5 years and 5 years, (iv) the risk-free interest rate of 3.7% and 3.4%, and (v) the expected dividend yield of 0% and 0%. Forfeitures are recognized when they occur. There were no performance stock units that vested in the three and nine months ending October 31, 2024. T he Company's performance against the defined goals is re-evaluated on a quarterly basis throughout the performance period and the recognition of the compensation expense is adjusted for subsequent changes in the estimated or actual outcome. The Company values stock options and warrants using the Black-Scholes option pricing model. Grants of stock-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the stock-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service period, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. The Company values Restricted Stock Units ("RSUs") at the closing stock price on the date of the grant.
Earnings Per Share	Earnings Per Share Basic net income or loss per share attributable to common stockholders excludes dilution and is computed by dividing net income attributable to common stockholders during the period by the weighted average number of common shares outstanding during the period. Diluted net income or loss per share reflects potential dilution and is computed by dividing net income attributable to common stockholders by the weighted average number of common shares outstanding during the period, which is increased by the number of additional common shares that would have been outstanding if the potential common shares had been issued. However, if the effect of any additional securities are anti-dilutive (i.e., resulting in a higher net income per share or lower net loss per share), they are excluded from the dilutive earnings per share computation. The dilutive effect of stock options, warrants, and restricted stock is calculated using the treasury stock method, and the dilutive effect of the Series B Preferred stock and PSUs is calculated using the if-converted method.
Income Taxes	Income Taxes Income taxes are provided in accordance with ASC 740, “ Accounting for Income Taxes. ” A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense results from the net change during the period of deferred tax assets and liabilities.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies an issuer’s accounting for convertible instruments by reducing the number of accounting models that require separate accounting for embedded conversion features. ASU 2020-06 also simplifies the settlement assessment that entities are required to perform to determine whether a contract qualifies for equity classification and makes targeted improvements to the disclosures for convertible instruments and earnings per share (EPS) guidance. This update was effective for the Company’s fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. In March 2023, the FASB issued ASU No. 2023-02, "Investments - Equity Method and Joint Ventures (Topic 323): Accounting for Investment Tax Credit Structures Using the Proportional Amortization Method." The amendments in this update permit reporting entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. This guidance was effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. In October 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-06, "Disclosure Improvements: Amendments - Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative." The FASB issued the standard to introduce changes to U.S. GAAP that originate in either SEC Regulation S-X or S-K, which are rules about the form and content of financial reports. The provisions of the standard are contingent when the SEC removes the related disclosure provisions from Regulation S-X and S-K. The Company does not expect the provisions of the standard to have a material impact on the Company's financial statements and related disclosures. In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The new guidance is intended to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendment is effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company is in the process of evaluating the impact that the adoption ASU No. 2023-07 will have to the financial statements and related disclosures. In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." The new guidance is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in the ASU address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. The amendment is effective retrospectively for fiscal years beginning after December 15, 2024, on a prospective basis, with early adoption permitted. The Company is in the process of evaluating the impact that the adoption of ASU No. 2023-09 will have to the financial statements and related disclosures. Management does not believe that any recently issued but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.

Nature of Operations and Basi_2

Nature of Operations and Basis of Presentation (Tables)	9 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Results of Operations	The following presents the unaudited results of operations for the period February 1, 2023 through June 28, 2023 of CIF (in thousands): For the Period Revenues $ 13,721 Net income $ 931

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Schedule of Inventories	Inventories by major category are as follows (in thousands): October 31, 2024 January 31, 2024 Raw materials and packaging $ 1,316 $ 1,159 Work in process 330 237 Finished goods 1,544 1,914 Total $ 3,190 $ 3,310
Schedule of Asset Lives	Asset lives for financial statement reporting of depreciation expense are: Machinery and equipment 2-7 years Furniture and fixtures 3-5 years Leasehold improvements * (*) Amortized on a straight-line basis over the shorter of the remaining lease term at the time the assets were placed in service or their estimated useful lives.
Schedule of Other Intangible Assets	Other intangible assets consist of trademarks, trade names and customer relationships. Intangible asset lives for financial statement reporting of amortization are: Tradenames and trademarks 3 years Customer relationships 4 – 5 years
Schedule of Expenses of Slotting Fees, Sales Discounts, and Variable Considerations	Expenses such as slotting fees, sales discounts, and variable considerations are accounted for as a direct reduction of revenues as follows (in thousands): For the Three Months Ended October 31, 2024 October 31, 2023 Gross Sales $ 32,333 $ 29,294 Less: Trade Incentives and Promotions 810 646 Net Sales $ 31,523 $ 28,648 For the Nine Months Ended October 31, 2024 October 31, 2023 Gross Sales $ 91,435 $ 78,309 Less: Trade Incentives and Promotions 1,692 1,750 Net Sales $ 89,743 $ 76,559
Schedule of Disaggregates Gross Revenue by Significant Geographic Area	The following table disaggregates gross revenue by significant geographic area for the three months ended October 31, 2024 and 2023 (in thousands): For the Three Months Ended October 31, 2024 October 31, 2023 Northeast $ 8,277 $ 9,317 Southeast 8,763 8,225 Midwest 7,049 6,116 West 8,244 5,636 Total gross sales $ 32,333 $ 29,294 For the Nine Months Ended October 31, 2024 October 31, 2023 Northeast $ 26,534 $ 27,267 Southeast 24,470 22,113 Midwest 19,201 14,371 West 21,230 14,558 Total gross sales $ 91,435 $ 78,309
Schedule of Reconciliation of Basic and Diluted Earnings Per Share to Net Income	The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income attributable to common stockholders per common share (in thousands, except per share data): For the Three Months Ended October 31, 2024 October 31, 2023 Numerator: Net income attributable to common stockholders $ 410 2,009 Effect of dilutive securities: — — Diluted net income $ 410 $ 2,009 Denominator: Weighted average common shares outstanding – basic 37,522 37,121 Dilutive securities (a): Restricted stock 266 447 Performance stock awards 1,600 — Options 54 78 Weighted average common shares outstanding and assumed conversion – diluted 39,442 37,646 Basic net income per common share $ 0.01 $ 0.05 Diluted net income per common share $ 0.01 $ 0.05 (a) – Anti-dilutive securities excluded — — For the Nine Months Ended October 31, 2024 October 31, 2023 Numerator: Net income attributable to common stockholders $ 2,111 $ 5,104 Effect of dilutive securities: — 49 Diluted net income $ 2,111 $ 5,153 Denominator: Weighted average common shares outstanding – basic 37,373 36,642 Dilutive securities (a): Restricted stock 238 384 Options 50 62 Performance stock awards 1,600 — Weighted average common shares outstanding and assumed conversion – diluted 39,261 37,088 Basic net income per common share $ 0.06 $ 0.14 Diluted net income per common share $ 0.05 $ 0.14 (a) – Anti-dilutive securities excluded — —
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The Company's financial assets that were accounted for at fair value on a recurring basis as of October 31, 2024 and January 31, 2024 were as follows (in thousands): October 31, 2024 January 31, 2024 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents $ 9,168 $ — $ — $ 9,168 $ 10,912 $ — $ — $ 10,912 Total $ 9,168 $ — $ — $ 9,168 $ 10,912 $ — $ — $ 10,912

Property Plant and Equipment,_2

Property Plant and Equipment, Net: (Tables)	9 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property Plant and Equipment, Net	Property plant and equipment, net on October 31, 2024 and January 31, 2024 were as follows (in thousands): October 31, 2024 January 31, 2024 Machinery and Equipment $ 7,948 $ 4,437 Furniture and Fixtures 242 252 Leasehold Improvements 5,848 2,956 14,038 7,645 Less: Accumulated Depreciation 4,189 3,209 Total $ 9,849 $ 4,436

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	9 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Net	Intangible assets, net, consisted of the following at October 31, 2024 (dollars in thousands): Gross Accumulated Net Carrying Weighted Customer relationships $ 6,418 $ (2,600) $ 3,818 2.55 Tradename and trademarks 79 (75) 4 0.16 Total intangible assets $ 6,497 $ (2,675) $ 3,822 Intangible assets, net consisted of the following at January 31, 2024 (dollars in thousands): Gross Accumulated Net Carrying Weighted Customer relationships $ 6,418 $ (1,463) $ 4,955 3.29 Tradename and trademarks 79 (55) 24 0.91 Total intangible assets $ 6,497 $ (1,518) $ 4,979
Schedule of Estimated Aggregate Amortization Expense	We expect the estimated aggregate amortization expense for each of the four succeeding fiscal years to be as follows (in thousands): 2025 (Remaining) $ 382 2026 1,513 2027 1,465 2028 462 Total $ 3,822

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	9 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Schedule of Restricted Stock Units Activity	The following is a summary of the Company’s restricted stock units activity: Restricted Weighted Average Grant Date Fair Value Non-vested restricted stock units - February 1, 2024 493,078 $ 1.91 Granted 97,026 $ 7.16 Vested (219,776) $ 2.61 Forfeited - $ - Outstanding – October 31, 2024 370,328 $ 2.87
Schedule of Option Activity	The following is a summary of the Company’s option activity: Options Weighted Average Weighted Aggregate Intrinsic Value Outstanding – February 1, 2024 117,500 $ 1.48 8.36 $ 333 Granted 38,806 $ 7.57 Exercised (37,500) $ 1.48 Expired/forfeited (15,000) $ 1.48 Outstanding – October 31, 2024 103,806 $ 3.76 8.47 $ 388 Exercisable – October 31, 2024 0 $ — 0.00 $ —

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2024
Leases [Abstract]
Schedule of Supplemental Cash Flow and Other Information Related to Leases	Supplemental cash flow and other information related to leases was as follows (in thousands): October 31, 2024 October 31, 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ (180) $ 237 Financing cash flows from finance leases 296 175 The following table shows the weighted average lease term and weighted average discount rate for our ROU lease assets: October 31, 2024 January 31, 2024 Weighted average remaining lease term (in years) Operating leases 5.20 6.57 Finance leases 4.70 4.49 Weighted average discount rate: Operating leases 5.82 % 4.85 % Finance leases 7.65 % 6.74 %
Schedule of Future Minimum Payments Required Under Maturities of Operating Lease Liabilities	Maturities of lease liabilities for each of the succeeding fiscal years are as follows (in thousands): For the fiscal years ended Finance Leases Operating Leases Total Maturities of Lease Liabilities 2025 remaining $ 132 $ 249 $ 381 2026 454 1,002 1,456 2027 406 503 909 2028 398 500 898 2029 302 507 809 Thereafter 293 839 1,132 Total undiscounted future lease payments 1,985 3,600 5,585 Less: imputed interest (341) (447) (788) Total present value of future lease liabilities $ 1,644 $ 3,153 $ 4,797
Schedule of Future Minimum Payments Required Under Maturities of Finance Lease Liabilities	Maturities of lease liabilities for each of the succeeding fiscal years are as follows (in thousands): For the fiscal years ended Finance Leases Operating Leases Total Maturities of Lease Liabilities 2025 remaining $ 132 $ 249 $ 381 2026 454 1,002 1,456 2027 406 503 909 2028 398 500 898 2029 302 507 809 Thereafter 293 839 1,132 Total undiscounted future lease payments 1,985 3,600 5,585 Less: imputed interest (341) (447) (788) Total present value of future lease liabilities $ 1,644 $ 3,153 $ 4,797

Nature of Operations and Basi_3

Nature of Operations and Basis of Presentation - Narrative (Details) - CIF - USD ($) $ in Thousands			3 Months Ended	12 Months Ended
	Jun. 28, 2025	Jun. 28, 2023	Jul. 31, 2024	Dec. 31, 2022
Business Acquisition [Line Items]
Ownership interest acquired (as a percent)				24%
Investment				$ 1,200
Payments to acquire businesses, gross		$ 1,000	$ 1,200	500
Common stock consideration				$ 700
Remaining ownership interest acquired (as a percent)		76%
Purchase price		$ 3,700
Promissory note consideration		$ 2,700
Forecast
Business Acquisition [Line Items]
Common stock consideration	$ 1,500

Nature of Operations and Basi_4

Nature of Operations and Basis of Presentation - Schedule of Results of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jun. 28, 2023	Oct. 31, 2024	Oct. 31, 2023
Business Acquisition [Line Items]
Revenues	$ 31,523	$ 28,648		$ 89,743	$ 76,559
Net income	$ 410	$ 2,009		$ 2,111	$ 5,153
CIF
Business Acquisition [Line Items]
Revenues			$ 13,721
Net income			$ 931

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended		9 Months Ended
	Oct. 31, 2024 USD ($) $ / shares shares	Oct. 31, 2023 USD ($)	Oct. 31, 2024 USD ($) Segment $ / shares shares	Oct. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of reportable segments | Segment			1
Cash, exceeded federally insured limits	$ 8,500,000		$ 8,500,000
Reserve for uncollectable accounts	93,000		93,000		$ 93,000
Uncollectible accounts written off	0	$ 0	0	$ 140,000
Reserve for obsolete inventory	95,000		95,000		95,000
Goodwill impairment losses	0		0
Research and development expenses	155,000	124,000	352,000	290,000
Advertising expenses	663,000	$ 380,000	1,480,000	$ 779,000
Deferred tax asset	$ 413,000		$ 413,000		$ 503,000
Executive Officer One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of common stock (in dollars per share) | $ / shares	$ 1.17		$ 1.17
Executive Officer Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of common stock (in dollars per share) | $ / shares	$ 1.40		$ 1.40
Performance stock awards
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vested (in shares) | shares	0		0
Performance stock awards | Executive Officer One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility (as a percent)			85.70%
Term of award (in years)			5 years
Risk-free interest rate (as a percent)			3.70%
Dividend yield (as a percent)			0%
Performance stock awards | Executive Officer Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility (as a percent)			87%
Term of award (in years)			5 years
Risk-free interest rate (as a percent)			3.40%
Dividend yield (as a percent)			0%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Inventories (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Accounting Policies [Abstract]
Raw materials and packaging	$ 1,316	$ 1,159
Work in process	330	237
Finished goods	1,544	1,914
Total	$ 3,190	$ 3,310

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Asset Lives (Details)	Oct. 31, 2024
Minimum | Machinery and equipment
Property, Plant and Equipment [Line Items]
Asset lives (in years)	2 years
Minimum | Furniture and fixtures
Property, Plant and Equipment [Line Items]
Asset lives (in years)	3 years
Maximum | Machinery and equipment
Property, Plant and Equipment [Line Items]
Asset lives (in years)	7 years
Maximum | Furniture and fixtures
Property, Plant and Equipment [Line Items]
Asset lives (in years)	5 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Other Intangible Assets (Details)	Oct. 31, 2024
Tradenames and trademarks
Finite-Lived Intangible Assets [Line Items]
Other intangible asset lives (in years)	3 years
Customer relationships | Minimum
Finite-Lived Intangible Assets [Line Items]
Other intangible asset lives (in years)	4 years
Customer relationships | Maximum
Finite-Lived Intangible Assets [Line Items]
Other intangible asset lives (in years)	5 years

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees, Sales Discounts and Variable Considerations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
Gross Sales	$ 32,333	$ 29,294	$ 91,435	$ 78,309
Less: Trade Incentives and Promotions	810	646	1,692	1,750
Net Sales	$ 31,523	$ 28,648	$ 89,743	$ 76,559

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Schedule of Disaggregates Gross Revenue by Significant Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Disaggregation of Revenue [Line Items]
Total gross sales	$ 32,333	$ 29,294	$ 91,435	$ 78,309
Northeast
Disaggregation of Revenue [Line Items]
Total gross sales	8,277	9,317	26,534	27,267
Southeast
Disaggregation of Revenue [Line Items]
Total gross sales	8,763	8,225	24,470	22,113
Midwest
Disaggregation of Revenue [Line Items]
Total gross sales	7,049	6,116	19,201	14,371
West
Disaggregation of Revenue [Line Items]
Total gross sales	$ 8,244	$ 5,636	$ 21,230	$ 14,558

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Earnings Per Share to Net Income (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Numerator:
Net income attributable to common stockholders	$ 410	$ 2,009	$ 2,111	$ 5,104
Effect of dilutive securities:	0	0	0	49
Diluted net income	$ 410	$ 2,009	$ 2,111	$ 5,153
Denominator:
Weighted average common shares outstanding – basic (in shares)	37,522,000	37,121,000	37,373,000	36,642,000
Weighted average common shares outstanding and assumed conversion – diluted (in shares)	39,442,000	37,646,000	39,261,000	37,088,000
Basic net income per common share (in dollars per share)	$ 0.01	$ 0.05	$ 0.06	$ 0.14
Diluted net income per common share (in dollars per share)	$ 0.01	$ 0.05	$ 0.05	$ 0.14
Anti-dilutive securities excluded (in shares)	0	0	0	0
Restricted stock
Denominator:
Dilutive securities (in shares)	266,000	447,000	238,000	384,000
Performance stock awards
Denominator:
Dilutive securities (in shares)	1,600,000	0	1,600,000	0
Options
Denominator:
Dilutive securities (in shares)	54,000	78,000	50,000	62,000

Summary of Significant Accou_11

Summary of Significant Accounting Policies - Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 9,168	$ 10,912
Total	9,168	10,912
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	9,168	10,912
Total	9,168	10,912
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Total	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Total	$ 0	$ 0

Property Plant and Equipment,_3

Property Plant and Equipment, Net: - Schedule of Property Plant and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 14,038	$ 7,645
Less: Accumulated Depreciation	4,189	3,209
Total	9,849	4,436
Machinery and Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	7,948	4,437
Furniture and Fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	242	252
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 5,848	$ 2,956

Property Plant and Equipment,_4

Property Plant and Equipment, Net: - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 451	$ 255	$ 1,057	$ 767

Intangible Assets, Net - Schedu

Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 6,497	$ 6,497
Accumulated Amortization	(2,675)	(1,518)
Net Carrying Amount	3,822	4,979
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	6,418	6,418
Accumulated Amortization	(2,600)	(1,463)
Net Carrying Amount	$ 3,818	$ 4,955
Weighted Average Remaining Life (years)	2 years 6 months 18 days	3 years 3 months 14 days
Tradename and trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 79	$ 79
Accumulated Amortization	(75)	(55)
Net Carrying Amount	$ 4	$ 24
Weighted Average Remaining Life (years)	1 month 28 days	10 months 28 days

Intangible Assets, Net - Narrat

Intangible Assets, Net - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 388	$ 388	$ 1,156	$ 692

Intangible Assets, Net - Sche_2

Intangible Assets, Net - Schedule of Estimated Aggregate Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
2025 (Remaining)	$ 382
2026	1,513
2027	1,465
2028	462
Net Carrying Amount	$ 3,822	$ 4,979

Related Party Transactions (Det

Related Party Transactions (Details) $ in Thousands	3 Months Ended		5 Months Ended	9 Months Ended
	Oct. 31, 2024 USD ($) extensionOption	Oct. 31, 2023 USD ($)	Jun. 28, 2023 USD ($)	Oct. 31, 2024 USD ($) extensionOption	Oct. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)	Dec. 31, 2022	Dec. 31, 2021 USD ($)
Related Party Transaction [Line Items]
Promissory notes – related parties	$ 2,250			$ 2,250		$ 1,950
Promissory note – related party, net of current	750			750		2,250
Net sales	$ 31,523	$ 28,648		$ 89,743	$ 76,559
CIF
Related Party Transaction [Line Items]
Ownership interest (as a percent)							24%
Net sales			$ 13,721
Related Party | CIF
Related Party Transaction [Line Items]
Ownership interest (as a percent)			24%
Net sales			$ 10,900
Commission expense			$ 175
Related Party | Farmingdale
Related Party Transaction [Line Items]
Number of options to extend lease | extensionOption	2			2
Rent payments	$ 81	96		$ 240	267
Related Party | Farmingdale | Renewal Option One
Related Party Transaction [Line Items]
Lease extension term (in years)	10 years			10 years
Related Party | Farmingdale | Renewal Option Two
Related Party Transaction [Line Items]
Lease extension term (in years)	10 years			10 years
Related Party | Farmingdale | December 31, 2026
Related Party Transaction [Line Items]
Rent payments				$ 20
Related Party | Farmingdale | End of Initial Lease Term
Related Party Transaction [Line Items]
Rent payments				24
Promissory Note | Related Party
Related Party Transaction [Line Items]
Promissory note								$ 3,000
Annual principal payments								$ 750
Accrued interest rate per annum (as a percent)								3.50%
Promissory note outstanding	$ 1,500			1,500		1,500
Promissory notes – related parties	750			750		750
Promissory note – related party, net of current	750			750		750
Interest expense	14	$ 20		40	$ 39
Accrued interest	$ 44			$ 44		$ 5

Loan and Security Agreements (D

Loan and Security Agreements (Details) - M&T Bank			3 Months Ended		9 Months Ended
	Dec. 04, 2023	Dec. 29, 2021 USD ($)	Oct. 31, 2024 USD ($)	Oct. 31, 2023 USD ($)	Oct. 31, 2024 USD ($)	Oct. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)
The Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Total available borrowings			$ 5,500,000		$ 5,500,000
Outstanding balance on line of credit			0		0		$ 0
Incurred interest			$ 0	$ 1,000	$ 0	$ 47,000
The Credit Facility | Line of Credit | Maximum
Line of Credit Facility [Line Items]
Advances limit, percent of eligible accounts receivable (as a percent)			80%		80%
Advances limit, percent of eligible inventory (as a percent)	50%
The Credit Facility | Line of Credit | Variable Rate Component One | Minimum
Line of Credit Facility [Line Items]
Senior Funded Debt/EBITDA ratio			2.25		2.25
The Credit Facility | Line of Credit | Variable Rate Component One | SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate					3.25%
The Credit Facility | Line of Credit | Variable Rate Component Two | Minimum
Line of Credit Facility [Line Items]
Senior Funded Debt/EBITDA ratio			1.50		1.50
The Credit Facility | Line of Credit | Variable Rate Component Two | Maximum
Line of Credit Facility [Line Items]
Senior Funded Debt/EBITDA ratio			2.25		2.25
The Credit Facility | Line of Credit | Variable Rate Component Two | SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate					2.75%
The Credit Facility | Line of Credit | Variable Rate Component Three | Maximum
Line of Credit Facility [Line Items]
Senior Funded Debt/EBITDA ratio			1.50		1.50
The Credit Facility | Line of Credit | Variable Rate Component Three | SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate					2.25%
Multiple Disbursement Term Loan
Line of Credit Facility [Line Items]
Incurred interest			$ 72,000	$ 112,000	$ 238,000	$ 350,000
Original principal amount		$ 7,500,000	3,300,000		3,300,000		4,600,000
Amortization period (in months)		60 months
Unamortized discount			$ 25,000		$ 25,000		$ 38,000
Multiple Disbursement Term Loan | Variable Loan Rate
Line of Credit Facility [Line Items]
Measurement base percent (as a percent)	0%
Multiple Disbursement Term Loan | Variable Rate Component One | Minimum
Line of Credit Facility [Line Items]
Senior Funded Debt/EBITDA ratio	2.25
Multiple Disbursement Term Loan | Variable Rate Component One | Variable Loan Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	3.50%
Multiple Disbursement Term Loan | Variable Rate Component Two | Minimum
Line of Credit Facility [Line Items]
Senior Funded Debt/EBITDA ratio	1.50
Multiple Disbursement Term Loan | Variable Rate Component Two | Maximum
Line of Credit Facility [Line Items]
Senior Funded Debt/EBITDA ratio	2.25
Multiple Disbursement Term Loan | Variable Rate Component Two | Variable Loan Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	3%
Multiple Disbursement Term Loan | Variable Rate Component Three | Maximum
Line of Credit Facility [Line Items]
Senior Funded Debt/EBITDA ratio	1.50
Multiple Disbursement Term Loan | Variable Rate Component Three | Variable Loan Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	2.50%

Concentrations (Details)

Concentrations (Details) - Customer Concentration Risk	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Customer One | Revenue Benchmark
Concentration Risk [Line Items]
Concentration risk, percentage (as a percent)	43%	39%	41%	22%
Customer One | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage (as a percent)			35%		20%
Customer Two | Revenue Benchmark
Concentration Risk [Line Items]
Concentration risk, percentage (as a percent)	10%	12%		14%
Customer Two | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage (as a percent)			17%		15%
Customer Three | Revenue Benchmark
Concentration Risk [Line Items]
Concentration risk, percentage (as a percent)				11%
Customer Three | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage (as a percent)					13%
Customer Four | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage (as a percent)					10%

Stockholders_ Equity - Narrativ

Stockholders’ Equity - Narrative (Details)			3 Months Ended			9 Months Ended
	May 15, 2024 USD ($) shares	Jun. 22, 2023 shares	Oct. 31, 2024 USD ($) $ / shares shares	Apr. 30, 2024 USD ($)	Oct. 31, 2023 USD ($)	Oct. 31, 2024 USD ($) day $ / shares shares	Oct. 31, 2023 USD ($)	Jan. 31, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Preferred stock authorized (in shares)			20,000,000			20,000,000
Preferred stock par value (in dollars per share) | $ / shares			$ 0.00001			$ 0.00001
Preferred shares issued upon conversion (in shares)			15			15
Conversion price (in dollars per share) | $ / shares			$ 2			$ 2
Trading days | day						20
Conversion discount (as a percent)						20%
Trading day period | day						20
Options exercised (in shares)						37,500
Weighted average exercise price (in dollars per share) | $ / shares						$ 1.48
Common stock issued (in shares)						38,000
Proceeds from exercise of stock options | $						$ 55,000	$ 65,000
Granted (in shares)						38,806
Unrecognized share-based compensation, options | $			$ 213,000			$ 213,000
Director
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
One-time settlement agreement charge | $				$ 900,000
Employees
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for settlement agreements | $			$ 20,000			$ 20,000
Common stock issued for settlement agreements (in shares)			3,007			3,007
Alfred D’Agostino | Director
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for settlement agreements | $	$ 113,000
Common stock issued for settlement agreements (in shares)	17,000
Steve Burns | Director
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for settlement agreements | $	$ 113,000
Common stock issued for settlement agreements (in shares)	17,000
Dean Janeway | Director
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for settlement agreements | $	$ 113,000
Common stock issued for settlement agreements (in shares)	17,000
Thomas Toto | Director
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for settlement agreements | $	$ 113,000
Common stock issued for settlement agreements (in shares)	17,000
Restricted Stock Units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation | $			$ 136,000		$ 167,000	$ 447,000	98,000
Unrecognized stock-based compensation expense, restricted stock units | $			996,000			996,000
Options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation | $			16,000		12,000	$ 23,000	53,000
Risk-free interest rate (as a percent)						3.50%
Expected life of grants (in years)						6 years
Expected volatility of underlying stock (as a percent)						76%
Dividend yield (as a percent)						0%
Options | Employees and Contractors
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation | $						$ (11,000)
Performance Stock Units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation | $			$ 91,000			$ 311,000
Performance Stock Units | Executive Officer One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate (as a percent)						3.70%
Expected life of grants (in years)						5 years
Expected volatility of underlying stock (as a percent)						85.70%
Dividend yield (as a percent)						0%
Minimum | Restricted Stock Units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Award vesting period (in years)						3 years
Maximum | Restricted Stock Units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Award vesting period (in years)						4 years
Preferred Stock, Conversion Period, One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Conversion period (in months)						6 months
Preferred Stock, Conversion Period, Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Conversion period (in months)						18 months
Series A Preferred Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Preferred stock authorized (in shares)			120,000			120,000		120,000
Preferred stock par value (in dollars per share) | $ / shares			$ 0.00001			$ 0.00001		$ 0.00001
Preferred stock outstanding (in shares)			0			0		0
Series B Preferred Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Preferred stock authorized (in shares)			200,000			200,000		200,000
Preferred stock par value (in dollars per share) | $ / shares			$ 0.00001			$ 0.00001		$ 0.00001
Preferred stock outstanding (in shares)			0			0		0
Cash dividend annual rate (as a percent)						8%
Conversion of Series B preferred stock (in shares)		819,000
Dividends paid | $			$ 0		$ 0	$ 0	$ 49,000

Stockholders_ Equity - Schedule

Stockholders’ Equity - Schedule of Restricted Stock Units Activity (Details) - Restricted Stock Units	9 Months Ended
	Oct. 31, 2024 $ / shares shares
Restricted Stock Units
Beginning balance (in shares) | shares	493,078
Granted (in shares) | shares	97,026
Vested (in shares) | shares	(219,776)
Forfeited (in shares) | shares	0
Ending balance (in shares) | shares	370,328
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 1.91
Granted (in dollars per share) | $ / shares	7.16
Vested (in dollars per share) | $ / shares	2.61
Forfeited (in dollars per share) | $ / shares	0
Ending balance (in dollars per share) | $ / shares	$ 2.87

Stockholders_ Equity - Schedu_2

Stockholders’ Equity - Schedule of Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2024	Jan. 31, 2024
Options
Outstanding – beginning balance (in shares)	117,500
Granted (in shares)	38,806
Exercised (in shares)	(37,500)
Expired/forfeited (in shares)	(15,000)
Outstanding – ending balance (in shares)	103,806	117,500
Exercisable (in shares)	0
Weighted Average Exercise Price
Outstanding – beginning balance (in dollars per share)	$ 1.48
Granted (in dollars per share)	7.57
Exercised (in dollars per share)	1.48
Expired/forfeited (in dollars per share)	1.48
Outstanding – ending balance (in dollars per share)	3.76	$ 1.48
Exercisable (in dollars per share)	$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Outstanding, weighted average remaining contractual life (in years)	8 years 5 months 19 days	8 years 4 months 9 days
Exercisable, weighted average remaining contractual life (in years)	0 years
Outstanding, aggregate intrinsic value	$ 388	$ 333
Exercisable, aggregate intrinsic value	$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Loss Contingencies [Line Items]
Royalty expense	$ 143	$ 119	$ 448	$ 437
Minimum
Loss Contingencies [Line Items]
Royalty expense			$ 125
Tranche One
Loss Contingencies [Line Items]
Percentage of royalty rate on net sales (as a percent)			6%
Tranche One | Maximum
Loss Contingencies [Line Items]
Net sales			$ 500
Tranche Two
Loss Contingencies [Line Items]
Percentage of royalty rate on net sales (as a percent)			4%
Tranche Two | Maximum
Loss Contingencies [Line Items]
Net sales			$ 2,500
Tranche Two | Minimum
Loss Contingencies [Line Items]
Net sales			$ 500
Tranche Three
Loss Contingencies [Line Items]
Percentage of royalty rate on net sales (as a percent)			2%
Tranche Three | Maximum
Loss Contingencies [Line Items]
Net sales			$ 20,000
Tranche Three | Minimum
Loss Contingencies [Line Items]
Net sales			$ 2,500
Tranche Four
Loss Contingencies [Line Items]
Percentage of royalty rate on net sales (as a percent)			1%
Tranche Four | Minimum
Loss Contingencies [Line Items]
Net sales			$ 20,000

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($)		9 Months Ended
	Aug. 21, 2024	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024
Lessee, Lease, Description [Line Items]
Rent payments, first year		$ 1,002,000
Rent payments, second year		503,000
Rent payments, third year		500,000
Rent payments, fourth year		507,000
Recognition of lease ROU asset and ROU liability	$ 615,000	873,000	$ 0
Write-off of lease ROU asset and ROU liability		(897,000)	$ 0
Monthly rental payments		$ 3,600,000
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, remaining lease term (in years)		6 months
Finance lease, remaining lease term (in years)		6 months
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, remaining lease term (in years)		7 years 1 month 6 days
Finance lease, remaining lease term (in years)		7 years 1 month 6 days
25 Branca Road
Lessee, Lease, Description [Line Items]
Monthly rental payments	36,000
25 Branca Road | Minimum
Lessee, Lease, Description [Line Items]
Monthly rental payments during renewal option	38,000
25 Branca Road | Maximum
Lessee, Lease, Description [Line Items]
Monthly rental payments during renewal option	$ 42,000
Building | Farmingdale, New York
Lessee, Lease, Description [Line Items]
Lease term (in years)				5 years
Rent payments, first year				$ 16,700
Rent payments, second year				17,200
Rent payments, third year				17,700
Rent payments, fourth year				18,200
Rent payments, fifth year				$ 18,800

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow and Other Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$ (180)	$ 237
Financing cash flows from finance leases	$ 296	$ 175
Weighted average remaining lease term (in years)
Operating leases	5 years 2 months 12 days		6 years 6 months 25 days
Finance leases	4 years 8 months 12 days		4 years 5 months 26 days
Weighted average discount rate:
Operating leases	5.82%		4.85%
Finance leases	7.65%		6.74%

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Lease Liabilities (Details) $ in Thousands	Oct. 31, 2024 USD ($)
Finance Leases
2025 remaining	$ 132
2026	454
2027	406
2028	398
2029	302
Thereafter	293
Total undiscounted future lease payments	1,985
Less: imputed interest	(341)
Total present value of future lease liabilities	1,644
Operating Leases
2025 remaining	249
2026	1,002
2027	503
2028	500
2029	507
Thereafter	839
Total undiscounted future lease payments	3,600
Less: imputed interest	(447)
Total present value of future lease liabilities	3,153
Total Maturities of Lease Liabilities
2025 remaining	381
2026	1,456
2027	909
2028	898
2029	809
Thereafter	1,132
Total undiscounted future lease payments	5,585
Less: imputed interest	(788)
Total present value of future lease liabilities	$ 4,797

Income Tax Provision (Details)

Income Tax Provision (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Effective tax rate (as a percent)	23.80%	25.10%	23.80%	25.10%
Net deferred tax asset	$ 413,000		$ 413,000		$ 503,000
Valuation allowance	$ 0		$ 0		$ 0